LGALS9 and glioblastoma: T7 peptide is modified on 293T cells, and its exosomes are used to deliver Galectin-9 siRNA, which can promote macrophage repolarization and inhibit the immunosuppression of glioblastoma (GBM) (Li et al., 2023).